Nobate GM (Skin) (15 gm) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Nelon Pharmaceuticals Pvt Ltd. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Clobetasol Propionate, Miconazole Nitrate,Neomycin. This drug comes in the form of Cream. The general packing available for this medicine consists of 15 gm and is priced at Rs 35 (arround $0.49 US Dollar)
Clobetasol Propionate Indication (Prescribed for or used as): short-term ffeatment only of severe resistant inflammatory skin disorders such as recalcitrant eczemas unresponsive to less potent corticosteroids; psoriasis
For more details on Clobetasol Propionate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clobetasol Propionate..
Miconazole Nitrate Indication (Prescribed for or used as):
For more details on Miconazole Nitrate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Miconazole Nitrate..
Neomycin Indication (Prescribed for or used as): Orally used for bacterial diarrhoeas and dysentery. Preparation of bowel before surgery. Hepatic coma. Topically for infected wound, ulcers, burn, external ear infections, conjunctivitis.
For more details on Neomycin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Neomycin..
Nobate GM (Skin) (15 gm) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 5 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Nobate GM (Skin) (15 gm), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Clobetasol Propionate-0.05% w/w Neomycin-0.5% w/w Miconazole Nitrate-2% w/w). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.